#South Korea #Incheon #Incheon National University #iTARGET #Microbial Engineering

Unlocking Hidden Genetic Potential in Microbes

In a pioneering study, researchers from Incheon National University have developed a new method aimed at tapping into the hidden genetic potential of microorganisms. This breakthrough is set to revolutionize the way we produce valuable compounds, including pharmaceuticals, food ingredients, biofuels, and industrial chemicals.

The Need for Efficient Microbial Production

As the global demand for sustainable and high-quality products continues to rise, engineers are increasingly turning to microbes as versatile production platforms. However, transforming these tiny organisms into efficient production factories has proven challenging. The optimization processes that allow microbial strains to produce goods at scale require a deep understanding of genetic modifications, which are often concealed within intricate cellular networks.

To tackle these challenges, the research team led by Professor Gyoo Yeol Jung and Professor Sungho Jang, in collaboration with experts from other universities, has unveiled a novel platform named iTARGET (Integrated Tn-seq and MAGE-assisted rapid genome engineering targeting). This innovative system is designed to quickly identify genetic changes that can significantly boost microbial production capabilities.

The iTARGET Platform

The iTARGET platform has been uniquely crafted to outperform existing methodologies, which either generate genetic variants or pinpoint beneficial mutations but rarely facilitate both. By integrating multiple technologies, iTARGET not only identifies beneficial genetic targets but also reveals combinations that enhance production efficiency.

In their study, published in the journal Trends in Biotechnology, the researchers applied this novel approach to the plant-derived compound naringenin, an essential precursor for several pharmaceuticals and bioactive substances.

Implementation and Results

The iTARGET workflow consists of several steps that streamline the identification of genetic modifications. Initially, random genetic alterations were introduced across the entire microbial genome. Following this, a built-in biosensor was employed to selectively enrich those microbial cells that produced higher levels of naringenin. This enriched population was then analyzed to pinpoint the specific genetic modifications responsible for the enhanced production.

The results were remarkable. The initial enrichment process saw a 1.7-fold increase in naringenin production compared to the control group. Further analysis led to the identification of ten promising genetic targets, nine of which had been experimentally validated to enhance production when individually manipulated. The most impactful single modification resulted in a staggering 2.3-fold increase in naringenin production. By combining two of the identified targets, the researchers achieved a cumulative enhancement of 2.8-fold, showcasing the efficacy of their approach.

Implications and Future Prospects

Beyond improving the production of specific compounds, the iTARGET platform represents a broader potential for discovery. Dr. Jang emphasizes that the primary goal of this technology is to rapidly enhance high-performance microbial factories for the bio-based production of a plethora of products, from bioplastics to biofuels and pharmaceutical intermediates. The versatility of iTARGET means it can adapt to various microorganisms and outputs, signifying a promising future in microbial biotechnology.

As new engineered biosensors for diverse chemicals continue to emerge, the iTARGET system holds the potential to optimize a wide array of valuable compounds, paving the way for sustainable production methods in the era of biomanufacturing. By leveraging this powerful platform, researchers aim to accelerate the sustainable production of medicines, chemicals, and fuels, thereby contributing meaningfully to the green bio-economy.

Reference: The original paper titled Integrated Tn-seq and MAGE-assisted rapid genome engineering targeting in Escherichia coli was published in Trends in Biotechnology.